CMB — Cambium Bio Balance Sheet
0.000.00%
- AU$8.78m
- AU$9.09m
- AU$0.67m
Annual balance sheet for Cambium Bio, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 5.86 | 0.164 | 0.303 | 2.86 | 0.166 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.84 | 0.559 | 0.39 | 0.257 | 0.263 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 6.73 | 0.787 | 2.46 | 3.2 | 0.468 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.034 | 0.017 | 0.001 | 0 | — |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 8.51 | 2.55 | 2.46 | 5.65 | 3.3 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.3 | 1.48 | 2.59 | 2.4 | 1.29 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 4.36 | 1.48 | 2.59 | 2.87 | 1.46 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 4.15 | 1.07 | -0.125 | 2.78 | 1.84 |
| Total Liabilities & Shareholders' Equity | 8.51 | 2.55 | 2.46 | 5.65 | 3.3 |
| Total Common Shares Outstanding |